2TG Stock Overview
STERIS plc provides infection prevention products and services worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
STERIS plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$173.42 |
| 52 Week High | US$232.90 |
| 52 Week Low | US$166.46 |
| Beta | 0.81 |
| 1 Month Change | 0% |
| 3 Month Change | 0.50% |
| 1 Year Change | -15.65% |
| 3 Year Change | 29.42% |
| 5 Year Change | n/a |
| Change since IPO | 542.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2TG | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -5.0% | -2.0% |
| 1Y | -15.7% | -13.6% | -0.3% |
Return vs Industry: 2TG underperformed the German Medical Equipment industry which returned -2.5% over the past year.
Return vs Market: 2TG underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| 2TG volatility | |
|---|---|
| 2TG Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2TG has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 2TG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 16,000 | Dan Carestio | www.steris.com |
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
STERIS plc Fundamentals Summary
| 2TG fundamental statistics | |
|---|---|
| Market cap | €17.98b |
| Earnings (TTM) | -€7.65m |
| Revenue (TTM) | €4.49b |
4.0x
P/S Ratio-2,352x
P/E RatioIs 2TG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2TG income statement (TTM) | |
|---|---|
| Revenue | US$4.78b |
| Cost of Revenue | US$2.70b |
| Gross Profit | US$2.08b |
| Other Expenses | US$2.09b |
| Earnings | -US$8.14m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.082 |
| Gross Margin | 43.49% |
| Net Profit Margin | -0.17% |
| Debt/Equity Ratio | 52.0% |
How did 2TG perform over the long term?
See historical performance and comparison